Name: Latest research reports of Emcure Pharmaceuticals Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Emcure Pharmaceuticals Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
20 Apr 2026	Emcure Pharma	Consensus Share Price Target	1647.50	1795.67	-	8.99	buy	pdf Detailed Estimates
05 Feb 2026	Emcure Pharma	BOB Capital Markets Ltd. Target	1647.50	1787.00	1482.30 (11.14%)	8.47	Buy	pdf post cache	Broker Report Emcure Pharma (BUY): Scaling Europe through long tail growth BOB Capital Markets Ltd. Sales/EBITDA/PAT was 6%/7%/-6% above our estimates. APAT was 6% above estimates. EBITDA margin was 16 bps above estimates pdf Copy Link Share on Share on Share on Share on Alert
12 Nov 2025	Emcure Pharma	BOB Capital Markets Ltd. Target	1647.50	1643.00	1337.40 (23.19%)	Target met	Buy	pdf post cache	Broker Report Emcure Pharma (BUY): In-line earnings; stable growth across geographies BOB Capital Markets Ltd. Sales/EBITDA/PAT reported 1.2%/2.7%/8.2% higher than our estimates. EBITDA margin was reported 28 bps higher, at 19.3% pdf Copy Link Share on Share on Share on Share on Alert
01 Oct 2025	Emcure Pharma	BOB Capital Markets Ltd.	1647.50	1530.00	1304.30 (26.31%)	Target met	Buy	pdf post cache	Broker Report [Initiation] Emcure Pharma (BUY): Immune to US tariff woes BOB Capital Markets Ltd. Domestic business is expected to recover with increasing traction from Sanofi's portfolio, leading to growth higher than IPM pdf Copy Link Share on Share on Share on Share on Alert
03 Jul 2024	Emcure Pharma	Hem Securities	1647.50				IPO Subscribe	pdf post cache	Broker Report EMCURE PHARMACEUTICAL LIMITED Hem Securities pdf Copy Link Share on Share on Share on Share on Alert
02 Jul 2024	Emcure Pharma	HDFC Securities	1647.50				IPO Note	pdf post cache	Broker Report IPO Note-Emcure Pharmaceuticals Limited-03072024 HDFC Securities Issue Snapshot: Issue Open: July 03 July 05, 2024 Price Band: Rs. 960 1008 (Discount of Rs 90 per sh for all eligible employees) *Issue Size: Up to Rs 1952.0 cr (Fresh issue up to Rs 800 cr + Offer for sale of up to 11,428,839 eq sh including employee reservation of upto 108,900 eq sh) Reservation for: QIB upto 50% eq sh Non-Institutional atleast 15% eq sh ((including 1/3rd for applications between Rs.2 lakhs to Rs.10 lakhs)) Retail atleast 35% eq sh Face Value: Rs 10 Book value: Rs 163.22 (March 31, 2024) Bid size: - 14 equity shares and in multiples thereof 100% Book built Issue IPO Note-Emcure Pharmaceuticals Limited-03072024 pdf Copy Link Share on Share on Share on Share on Alert
02 Jul 2024	Emcure Pharma	Ashika Research	1647.50				IPO Note	pdf post cache	Broker Report IPO Note Emcure Pharmaceuticals Ltd. Ashika Research pdf Copy Link Share on Share on Share on Share on Alert
02 Jul 2024	Emcure Pharma	SBI Securities	1647.50				IPO Subscribe	pdf post cache	Broker Report Emcure Pharmaceuticals Limited IPO Note SBI Securities pdf Copy Link Share on Share on Share on Share on Alert
02 Jul 2024	Emcure Pharma	Ventura	1647.50				IPO Subscribe	pdf post cache	Broker Report EMCURE PHARMACEUTICALS LTD. Ventura IPO NOTE pdf Copy Link Share on Share on Share on Share on Alert

New 52W High in past week

Emcure Pharmaceuticals Ltd. share price target

Emcure Pharmaceuticals Ltd. has an average share price target of 1787. The consensus estimate represents an upside of 8.47% from the last price of 1647.50. View 4 reports from 1 analysts offering long-term price targets for Emcure Pharmaceuticals Ltd..

Emcure Pharma (BUY): Scaling Europe through long tail growth

Emcure Pharma (BUY): In-line earnings; stable growth across geographies

[Initiation] Emcure Pharma (BUY): Immune to US tariff woes

EMCURE PHARMACEUTICAL LIMITED

IPO Note-Emcure Pharmaceuticals Limited-03072024

IPO Note Emcure Pharmaceuticals Ltd.

Emcure Pharmaceuticals Limited IPO Note

EMCURE PHARMACEUTICALS LTD.

Advisor Screeners